1. Home
  2. CAH vs KVUE Comparison

CAH vs KVUE Comparison

Compare CAH & KVUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cardinal Health Inc.

CAH

Cardinal Health Inc.

HOLD

Current Price

$198.38

Market Cap

49.4B

Sector

Health Care

ML Signal

HOLD

Logo Kenvue Inc.

KVUE

Kenvue Inc.

HOLD

Current Price

$17.26

Market Cap

39.9B

ML Signal

HOLD

Company Overview

Basic Information
Metric
CAH
KVUE
Founded
1979
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Other Pharmaceuticals
Specialty Chemicals
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
49.4B
39.9B
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
CAH
KVUE
Price
$198.38
$17.26
Analyst Decision
Buy
Buy
Analyst Count
12
13
Target Price
$200.25
$20.31
AVG Volume (30 Days)
2.4M
36.1M
Earning Date
01-29-2026
11-03-2025
Dividend Yield
1.03%
4.79%
EPS Growth
27.25
35.31
EPS
6.63
0.75
Revenue
$234,310,000,000.00
$15,006,000,000.00
Revenue This Year
$16.60
N/A
Revenue Next Year
$8.92
$2.81
P/E Ratio
$29.91
$23.16
Revenue Growth
4.39
N/A
52 Week Low
$114.60
$14.02
52 Week High
$214.93
$25.17

Technical Indicators

Market Signals
Indicator
CAH
KVUE
Relative Strength Index (RSI) 50.58 60.82
Support Level $197.81 $16.70
Resistance Level $202.22 $17.19
Average True Range (ATR) 3.60 0.34
MACD -2.98 0.02
Stochastic Oscillator 5.24 84.46

Price Performance

Historical Comparison
CAH
KVUE

About CAH Cardinal Health Inc.

Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.

About KVUE Kenvue Inc.

Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.

Share on Social Networks: